1. Home
  2. IRON vs MEOH Comparison

IRON vs MEOH Comparison

Compare IRON & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$73.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Methanex Corporation

MEOH

Methanex Corporation

HOLD

Current Price

$47.70

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
MEOH
Founded
2017
1968
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IRON
MEOH
Price
$73.54
$47.70
Analyst Decision
Strong Buy
Buy
Analyst Count
12
9
Target Price
$110.08
$48.67
AVG Volume (30 Days)
526.7K
665.1K
Earning Date
02-26-2026
03-05-2026
Dividend Yield
N/A
1.57%
EPS Growth
N/A
40.35
EPS
N/A
2.98
Revenue
N/A
$3,569,374,000.00
Revenue This Year
N/A
$1.99
Revenue Next Year
N/A
$12.55
P/E Ratio
N/A
$15.85
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$25.46
52 Week High
$99.50
$52.81

Technical Indicators

Market Signals
Indicator
IRON
MEOH
Relative Strength Index (RSI) 41.49 54.83
Support Level $76.00 $46.66
Resistance Level $83.93 $51.94
Average True Range (ATR) 4.20 1.86
MACD 0.20 -0.36
Stochastic Oscillator 13.69 26.41

Price Performance

Historical Comparison
IRON
MEOH

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: